Related Experiment Video
Updated: May 14, 2026

07:33
In Vitro Application of a Wireless Sensor in Flexion-Extension Gap Balance of Unicompartmental Knee Arthroplasty
Published on: May 5, 2023
The EIUS unicompartmental knee design: early failure in elderly patients
C Lowry Barnes1, Daniel Lincoln, Becky Wilson
1Department of Orthopaedics, Arkansas Specialty Orthopaedics, Little Rock, Arkansas.
The Journal of Knee Surgery
|January 30, 2013
Summary
This study on elderly patients undergoing unicompartmental knee replacement found a 14.7% failure rate within 5 years. Most remaining patients experienced long-term pain relief after 8 years.
Area of Science:
- Orthopedic Surgery
- Biomedical Engineering
Background:
- Unicompartmental knee replacement (UKR) is an alternative to total knee replacement for specific osteoarthritis cases.
- Elderly patients present unique challenges and considerations for joint replacement surgery.
Purpose of the Study:
- To evaluate the outcomes of the EIUS Unicompartmental Knee System in elderly patients.
- To assess the long-term efficacy and failure rates of this specific knee prosthesis.
Main Methods:
- Retrospective analysis of 34 unicompartmental knee replacements in 28 elderly patients (mean age 78.7 years).
- All surgeries performed by a single, experienced surgeon using the EIUS Unicompartmental Knee System.
- Follow-up included Knee Society Score up to 5 years and phone interviews for a minimum of 8 years, with revision as the endpoint.
Main Results:
- The 5-year failure rate requiring revision was 14.7% (5 knees), with a mean time to failure of 25.6 months.
- At 8 years, 3 patients (4 knees) died unrelated to the implant, and 2 patients (4 knees) were lost to follow-up.
- The majority of non-revised knees remained pain and symptom-free at the 8-year minimum follow-up.
Conclusions:
- Early failures of the EIUS Unicompartmental Knee System may be linked to prosthesis design and instrumentation rather than surgical technique.
- While early failures occurred, the majority of elderly patients in this cohort experienced sustained pain relief and symptom freedom long-term.